nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—type 2 diabetes mellitus	0.266	1	CbGaD
Fulvestrant—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0415	0.152	CbGbCtD
Fulvestrant—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.037	0.136	CbGbCtD
Fulvestrant—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0338	0.124	CbGbCtD
Fulvestrant—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0296	0.109	CbGbCtD
Fulvestrant—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0267	0.0982	CbGbCtD
Fulvestrant—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0203	0.0744	CbGbCtD
Fulvestrant—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0194	0.0713	CbGbCtD
Fulvestrant—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0194	0.0713	CbGbCtD
Fulvestrant—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0184	0.0675	CbGbCtD
Fulvestrant—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0137	0.0503	CbGbCtD
Fulvestrant—CYP3A4—Losartan—type 2 diabetes mellitus	0.0125	0.046	CbGbCtD
Fulvestrant—NR1H4—nephron tubule—type 2 diabetes mellitus	0.0033	0.0639	CbGeAlD
Fulvestrant—ESRRA—islet of Langerhans—type 2 diabetes mellitus	0.00313	0.0607	CbGeAlD
Fulvestrant—EPHX2—retina—type 2 diabetes mellitus	0.00306	0.0593	CbGeAlD
Fulvestrant—NR1H4—cardiovascular system—type 2 diabetes mellitus	0.00296	0.0574	CbGeAlD
Fulvestrant—NR1H4—kidney—type 2 diabetes mellitus	0.0029	0.0561	CbGeAlD
Fulvestrant—EPHX2—nephron tubule—type 2 diabetes mellitus	0.00288	0.0558	CbGeAlD
Fulvestrant—NR1H4—cortex of kidney—type 2 diabetes mellitus	0.00282	0.0547	CbGeAlD
Fulvestrant—ESRRA—nephron tubule—type 2 diabetes mellitus	0.00252	0.0489	CbGeAlD
Fulvestrant—EPHX2—cortex of kidney—type 2 diabetes mellitus	0.00247	0.0478	CbGeAlD
Fulvestrant—EPHX2—adipose tissue—type 2 diabetes mellitus	0.00228	0.0442	CbGeAlD
Fulvestrant—ESRRA—cardiovascular system—type 2 diabetes mellitus	0.00227	0.0439	CbGeAlD
Fulvestrant—ESRRA—kidney—type 2 diabetes mellitus	0.00222	0.043	CbGeAlD
Fulvestrant—ESRRA—pancreas—type 2 diabetes mellitus	0.0022	0.0427	CbGeAlD
Fulvestrant—ESRRA—cortex of kidney—type 2 diabetes mellitus	0.00216	0.0419	CbGeAlD
Fulvestrant—ESRRA—adipose tissue—type 2 diabetes mellitus	0.002	0.0387	CbGeAlD
Fulvestrant—NR1H4—liver—type 2 diabetes mellitus	0.00183	0.0355	CbGeAlD
Fulvestrant—EPHX2—liver—type 2 diabetes mellitus	0.0016	0.031	CbGeAlD
Fulvestrant—ESRRA—liver—type 2 diabetes mellitus	0.0014	0.0272	CbGeAlD
Fulvestrant—ESR2—cardiovascular system—type 2 diabetes mellitus	0.00136	0.0264	CbGeAlD
Fulvestrant—ESR2—kidney—type 2 diabetes mellitus	0.00133	0.0258	CbGeAlD
Fulvestrant—ESR1—cardiovascular system—type 2 diabetes mellitus	0.000932	0.0181	CbGeAlD
Fulvestrant—Estradiol—SHBG—type 2 diabetes mellitus	0.000926	0.329	CrCbGaD
Fulvestrant—ESR1—kidney—type 2 diabetes mellitus	0.000912	0.0177	CbGeAlD
Fulvestrant—ESR2—liver—type 2 diabetes mellitus	0.000841	0.0163	CbGeAlD
Fulvestrant—ESR1—adipose tissue—type 2 diabetes mellitus	0.000822	0.0159	CbGeAlD
Fulvestrant—Estradiol—AR—type 2 diabetes mellitus	0.000812	0.288	CrCbGaD
Fulvestrant—ESR1—liver—type 2 diabetes mellitus	0.000576	0.0112	CbGeAlD
Fulvestrant—CYP3A4—kidney—type 2 diabetes mellitus	0.000509	0.00986	CbGeAlD
Fulvestrant—Estradiol—CYP1A2—type 2 diabetes mellitus	0.000482	0.171	CrCbGaD
Fulvestrant—CYP3A4—liver—type 2 diabetes mellitus	0.000322	0.00623	CbGeAlD
Fulvestrant—Estradiol—CYP3A4—type 2 diabetes mellitus	0.000319	0.113	CrCbGaD
Fulvestrant—Estradiol—ALB—type 2 diabetes mellitus	0.000279	0.0988	CrCbGaD
Fulvestrant—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000216	0.000869	CcSEcCtD
Fulvestrant—Infection—Orlistat—type 2 diabetes mellitus	0.000215	0.000867	CcSEcCtD
Fulvestrant—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000215	0.000866	CcSEcCtD
Fulvestrant—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000214	0.000863	CcSEcCtD
Fulvestrant—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000214	0.000862	CcSEcCtD
Fulvestrant—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000213	0.000859	CcSEcCtD
Fulvestrant—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000213	0.000858	CcSEcCtD
Fulvestrant—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000213	0.000858	CcSEcCtD
Fulvestrant—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000213	0.000857	CcSEcCtD
Fulvestrant—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000212	0.000856	CcSEcCtD
Fulvestrant—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000212	0.000856	CcSEcCtD
Fulvestrant—Urticaria—Glyburide—type 2 diabetes mellitus	0.000211	0.00085	CcSEcCtD
Fulvestrant—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000211	0.00085	CcSEcCtD
Fulvestrant—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000211	0.000849	CcSEcCtD
Fulvestrant—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00021	0.000848	CcSEcCtD
Fulvestrant—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00021	0.000847	CcSEcCtD
Fulvestrant—Back pain—Losartan—type 2 diabetes mellitus	0.00021	0.000846	CcSEcCtD
Fulvestrant—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00021	0.000846	CcSEcCtD
Fulvestrant—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00021	0.000846	CcSEcCtD
Fulvestrant—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000209	0.000844	CcSEcCtD
Fulvestrant—Anorexia—Valsartan—type 2 diabetes mellitus	0.000209	0.000842	CcSEcCtD
Fulvestrant—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000208	0.00084	CcSEcCtD
Fulvestrant—Chest pain—Metformin—type 2 diabetes mellitus	0.000208	0.000839	CcSEcCtD
Fulvestrant—Myalgia—Metformin—type 2 diabetes mellitus	0.000208	0.000839	CcSEcCtD
Fulvestrant—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000207	0.000835	CcSEcCtD
Fulvestrant—Headache—Pioglitazone—type 2 diabetes mellitus	0.000207	0.000835	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000207	0.000833	CcSEcCtD
Fulvestrant—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000206	0.000832	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000206	0.00083	CcSEcCtD
Fulvestrant—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000206	0.000829	CcSEcCtD
Fulvestrant—Nausea—Glipizide—type 2 diabetes mellitus	0.000205	0.000826	CcSEcCtD
Fulvestrant—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000205	0.000825	CcSEcCtD
Fulvestrant—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000204	0.000823	CcSEcCtD
Fulvestrant—Pain—Gliclazide—type 2 diabetes mellitus	0.000204	0.000822	CcSEcCtD
Fulvestrant—Constipation—Gliclazide—type 2 diabetes mellitus	0.000204	0.000822	CcSEcCtD
Fulvestrant—Rash—Glimepiride—type 2 diabetes mellitus	0.000203	0.000818	CcSEcCtD
Fulvestrant—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000203	0.000818	CcSEcCtD
Fulvestrant—Rash—Sitagliptin—type 2 diabetes mellitus	0.000202	0.000816	CcSEcCtD
Fulvestrant—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000202	0.000815	CcSEcCtD
Fulvestrant—Headache—Glimepiride—type 2 diabetes mellitus	0.000202	0.000813	CcSEcCtD
Fulvestrant—Cough—Irbesartan—type 2 diabetes mellitus	0.000201	0.000811	CcSEcCtD
Fulvestrant—Headache—Sitagliptin—type 2 diabetes mellitus	0.000201	0.000811	CcSEcCtD
Fulvestrant—Anaemia—Losartan—type 2 diabetes mellitus	0.000201	0.000809	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.0002	0.000805	CcSEcCtD
Fulvestrant—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000199	0.000801	CcSEcCtD
Fulvestrant—Angioedema—Losartan—type 2 diabetes mellitus	0.000198	0.0008	CcSEcCtD
Fulvestrant—Infection—Metformin—type 2 diabetes mellitus	0.000198	0.000799	CcSEcCtD
Fulvestrant—Insomnia—Valsartan—type 2 diabetes mellitus	0.000198	0.000799	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000197	0.000795	CcSEcCtD
Fulvestrant—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000197	0.000793	CcSEcCtD
Fulvestrant—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000196	0.000792	CcSEcCtD
Fulvestrant—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000196	0.000792	CcSEcCtD
Fulvestrant—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000196	0.000792	CcSEcCtD
Fulvestrant—Insomnia—Orlistat—type 2 diabetes mellitus	0.000196	0.000789	CcSEcCtD
Fulvestrant—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000196	0.000789	CcSEcCtD
Fulvestrant—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000196	0.000789	CcSEcCtD
Fulvestrant—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000196	0.000789	CcSEcCtD
Fulvestrant—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000195	0.000787	CcSEcCtD
Fulvestrant—Vertigo—Losartan—type 2 diabetes mellitus	0.000195	0.000786	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000195	0.000786	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000195	0.000786	CcSEcCtD
Fulvestrant—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000194	0.000784	CcSEcCtD
Fulvestrant—Leukopenia—Losartan—type 2 diabetes mellitus	0.000194	0.000783	CcSEcCtD
Fulvestrant—Skin disorder—Metformin—type 2 diabetes mellitus	0.000194	0.000781	CcSEcCtD
Fulvestrant—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000193	0.000779	CcSEcCtD
Fulvestrant—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000193	0.000777	CcSEcCtD
Fulvestrant—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000193	0.000777	CcSEcCtD
Fulvestrant—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000192	0.000774	CcSEcCtD
Fulvestrant—Nausea—Glimepiride—type 2 diabetes mellitus	0.000191	0.000771	CcSEcCtD
Fulvestrant—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000191	0.000768	CcSEcCtD
Fulvestrant—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00019	0.000768	CcSEcCtD
Fulvestrant—Asthenia—Glyburide—type 2 diabetes mellitus	0.00019	0.000768	CcSEcCtD
Fulvestrant—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00019	0.000768	CcSEcCtD
Fulvestrant—Anorexia—Metformin—type 2 diabetes mellitus	0.00019	0.000767	CcSEcCtD
Fulvestrant—Cough—Losartan—type 2 diabetes mellitus	0.000189	0.000764	CcSEcCtD
Fulvestrant—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000189	0.000764	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000189	0.000762	CcSEcCtD
Fulvestrant—Fatigue—Valsartan—type 2 diabetes mellitus	0.000189	0.000761	CcSEcCtD
Fulvestrant—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000188	0.00076	CcSEcCtD
Fulvestrant—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000188	0.00076	CcSEcCtD
Fulvestrant—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000188	0.000759	CcSEcCtD
Fulvestrant—Pruritus—Glyburide—type 2 diabetes mellitus	0.000188	0.000757	CcSEcCtD
Fulvestrant—Constipation—Valsartan—type 2 diabetes mellitus	0.000187	0.000755	CcSEcCtD
Fulvestrant—Infection—Irbesartan—type 2 diabetes mellitus	0.000187	0.000754	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000187	0.000753	CcSEcCtD
Fulvestrant—Fatigue—Orlistat—type 2 diabetes mellitus	0.000187	0.000752	CcSEcCtD
Fulvestrant—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000186	0.00075	CcSEcCtD
Fulvestrant—Pain—Orlistat—type 2 diabetes mellitus	0.000185	0.000746	CcSEcCtD
Fulvestrant—Arthralgia—Losartan—type 2 diabetes mellitus	0.000185	0.000745	CcSEcCtD
Fulvestrant—Chest pain—Losartan—type 2 diabetes mellitus	0.000185	0.000745	CcSEcCtD
Fulvestrant—Myalgia—Losartan—type 2 diabetes mellitus	0.000185	0.000745	CcSEcCtD
Fulvestrant—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000185	0.000744	CcSEcCtD
Fulvestrant—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000185	0.000744	CcSEcCtD
Fulvestrant—Anxiety—Losartan—type 2 diabetes mellitus	0.000184	0.000742	CcSEcCtD
Fulvestrant—Rash—Bromocriptine—type 2 diabetes mellitus	0.000183	0.000738	CcSEcCtD
Fulvestrant—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000183	0.000738	CcSEcCtD
Fulvestrant—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000183	0.000737	CcSEcCtD
Fulvestrant—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000182	0.000734	CcSEcCtD
Fulvestrant—Headache—Bromocriptine—type 2 diabetes mellitus	0.000182	0.000734	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000182	0.000733	CcSEcCtD
Fulvestrant—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000182	0.000732	CcSEcCtD
Fulvestrant—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000179	0.000723	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000179	0.000722	CcSEcCtD
Fulvestrant—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000179	0.000722	CcSEcCtD
Fulvestrant—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000178	0.000717	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000177	0.000714	CcSEcCtD
Fulvestrant—Infection—Losartan—type 2 diabetes mellitus	0.000176	0.00071	CcSEcCtD
Fulvestrant—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000176	0.000708	CcSEcCtD
Fulvestrant—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000176	0.000708	CcSEcCtD
Fulvestrant—Urticaria—Valsartan—type 2 diabetes mellitus	0.000174	0.000702	CcSEcCtD
Fulvestrant—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000174	0.0007	CcSEcCtD
Fulvestrant—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000173	0.000699	CcSEcCtD
Fulvestrant—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000173	0.000698	CcSEcCtD
Fulvestrant—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000172	0.000695	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000172	0.000694	CcSEcCtD
Fulvestrant—Fatigue—Metformin—type 2 diabetes mellitus	0.000172	0.000693	CcSEcCtD
Fulvestrant—Urticaria—Orlistat—type 2 diabetes mellitus	0.000172	0.000693	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000171	0.000691	CcSEcCtD
Fulvestrant—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000171	0.00069	CcSEcCtD
Fulvestrant—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000171	0.00069	CcSEcCtD
Fulvestrant—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000171	0.00069	CcSEcCtD
Fulvestrant—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000171	0.00069	CcSEcCtD
Fulvestrant—Constipation—Metformin—type 2 diabetes mellitus	0.000171	0.000688	CcSEcCtD
Fulvestrant—Angioedema—Ramipril—type 2 diabetes mellitus	0.00017	0.000686	CcSEcCtD
Fulvestrant—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000169	0.000681	CcSEcCtD
Fulvestrant—Anorexia—Losartan—type 2 diabetes mellitus	0.000169	0.000681	CcSEcCtD
Fulvestrant—Vomiting—Glyburide—type 2 diabetes mellitus	0.000169	0.000681	CcSEcCtD
Fulvestrant—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000169	0.00068	CcSEcCtD
Fulvestrant—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000168	0.000677	CcSEcCtD
Fulvestrant—Rash—Glyburide—type 2 diabetes mellitus	0.000167	0.000675	CcSEcCtD
Fulvestrant—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000167	0.000674	CcSEcCtD
Fulvestrant—Vertigo—Ramipril—type 2 diabetes mellitus	0.000167	0.000674	CcSEcCtD
Fulvestrant—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000167	0.000672	CcSEcCtD
Fulvestrant—Headache—Glyburide—type 2 diabetes mellitus	0.000166	0.000671	CcSEcCtD
Fulvestrant—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000166	0.000668	CcSEcCtD
Fulvestrant—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000164	0.00066	CcSEcCtD
Fulvestrant—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000163	0.000658	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000163	0.000658	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000162	0.000655	CcSEcCtD
Fulvestrant—Cough—Ramipril—type 2 diabetes mellitus	0.000162	0.000655	CcSEcCtD
Fulvestrant—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000162	0.000654	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000161	0.000651	CcSEcCtD
Fulvestrant—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000161	0.000651	CcSEcCtD
Fulvestrant—Pain—Irbesartan—type 2 diabetes mellitus	0.000161	0.000649	CcSEcCtD
Fulvestrant—Constipation—Irbesartan—type 2 diabetes mellitus	0.000161	0.000649	CcSEcCtD
Fulvestrant—Insomnia—Losartan—type 2 diabetes mellitus	0.00016	0.000646	CcSEcCtD
Fulvestrant—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000159	0.000643	CcSEcCtD
Fulvestrant—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000159	0.000641	CcSEcCtD
Fulvestrant—Urticaria—Metformin—type 2 diabetes mellitus	0.000158	0.000639	CcSEcCtD
Fulvestrant—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000158	0.000639	CcSEcCtD
Fulvestrant—Chest pain—Ramipril—type 2 diabetes mellitus	0.000158	0.000639	CcSEcCtD
Fulvestrant—Myalgia—Ramipril—type 2 diabetes mellitus	0.000158	0.000639	CcSEcCtD
Fulvestrant—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000158	0.000637	CcSEcCtD
Fulvestrant—Anxiety—Ramipril—type 2 diabetes mellitus	0.000158	0.000637	CcSEcCtD
Fulvestrant—Nausea—Glyburide—type 2 diabetes mellitus	0.000158	0.000636	CcSEcCtD
Fulvestrant—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000158	0.000636	CcSEcCtD
Fulvestrant—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000158	0.000636	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000157	0.000634	CcSEcCtD
Fulvestrant—Asthenia—Valsartan—type 2 diabetes mellitus	0.000157	0.000634	CcSEcCtD
Fulvestrant—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000156	0.000629	CcSEcCtD
Fulvestrant—Asthenia—Orlistat—type 2 diabetes mellitus	0.000155	0.000626	CcSEcCtD
Fulvestrant—Pruritus—Valsartan—type 2 diabetes mellitus	0.000155	0.000625	CcSEcCtD
Fulvestrant—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000154	0.000621	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000154	0.000621	CcSEcCtD
Fulvestrant—Pruritus—Orlistat—type 2 diabetes mellitus	0.000153	0.000617	CcSEcCtD
Fulvestrant—Fatigue—Losartan—type 2 diabetes mellitus	0.000153	0.000616	CcSEcCtD
Fulvestrant—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000152	0.000611	CcSEcCtD
Fulvestrant—Constipation—Losartan—type 2 diabetes mellitus	0.000151	0.000611	CcSEcCtD
Fulvestrant—Pain—Losartan—type 2 diabetes mellitus	0.000151	0.000611	CcSEcCtD
Fulvestrant—Rash—Gliclazide—type 2 diabetes mellitus	0.00015	0.000606	CcSEcCtD
Fulvestrant—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00015	0.000605	CcSEcCtD
Fulvestrant—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00015	0.000604	CcSEcCtD
Fulvestrant—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00015	0.000603	CcSEcCtD
Fulvestrant—Headache—Gliclazide—type 2 diabetes mellitus	0.000149	0.000602	CcSEcCtD
Fulvestrant—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000149	0.000601	CcSEcCtD
Fulvestrant—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000149	0.0006	CcSEcCtD
Fulvestrant—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000149	0.0006	CcSEcCtD
Fulvestrant—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000148	0.000597	CcSEcCtD
Fulvestrant—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000148	0.000595	CcSEcCtD
Fulvestrant—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000147	0.000592	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000145	0.000584	CcSEcCtD
Fulvestrant—Dizziness—Valsartan—type 2 diabetes mellitus	0.000145	0.000584	CcSEcCtD
Fulvestrant—Anorexia—Ramipril—type 2 diabetes mellitus	0.000145	0.000584	CcSEcCtD
Fulvestrant—Dizziness—Orlistat—type 2 diabetes mellitus	0.000143	0.000577	CcSEcCtD
Fulvestrant—Asthenia—Metformin—type 2 diabetes mellitus	0.000143	0.000577	CcSEcCtD
Fulvestrant—Nausea—Gliclazide—type 2 diabetes mellitus	0.000142	0.000571	CcSEcCtD
Fulvestrant—Pruritus—Metformin—type 2 diabetes mellitus	0.000141	0.000569	CcSEcCtD
Fulvestrant—Urticaria—Losartan—type 2 diabetes mellitus	0.000141	0.000567	CcSEcCtD
Fulvestrant—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00014	0.000565	CcSEcCtD
Fulvestrant—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00014	0.000565	CcSEcCtD
Fulvestrant—Vomiting—Valsartan—type 2 diabetes mellitus	0.000139	0.000561	CcSEcCtD
Fulvestrant—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000139	0.000559	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000138	0.000558	CcSEcCtD
Fulvestrant—Rash—Valsartan—type 2 diabetes mellitus	0.000138	0.000557	CcSEcCtD
Fulvestrant—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000138	0.000556	CcSEcCtD
Fulvestrant—Vomiting—Orlistat—type 2 diabetes mellitus	0.000138	0.000555	CcSEcCtD
Fulvestrant—Insomnia—Ramipril—type 2 diabetes mellitus	0.000137	0.000554	CcSEcCtD
Fulvestrant—Headache—Valsartan—type 2 diabetes mellitus	0.000137	0.000553	CcSEcCtD
Fulvestrant—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000136	0.00055	CcSEcCtD
Fulvestrant—Rash—Orlistat—type 2 diabetes mellitus	0.000136	0.00055	CcSEcCtD
Fulvestrant—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000136	0.00055	CcSEcCtD
Fulvestrant—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000136	0.00055	CcSEcCtD
Fulvestrant—Headache—Orlistat—type 2 diabetes mellitus	0.000136	0.000547	CcSEcCtD
Fulvestrant—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000135	0.000546	CcSEcCtD
Fulvestrant—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000544	CcSEcCtD
Fulvestrant—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000134	0.000539	CcSEcCtD
Fulvestrant—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000133	0.000537	CcSEcCtD
Fulvestrant—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000132	0.000532	CcSEcCtD
Fulvestrant—Dizziness—Metformin—type 2 diabetes mellitus	0.000132	0.000532	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.000529	CcSEcCtD
Fulvestrant—Fatigue—Ramipril—type 2 diabetes mellitus	0.000131	0.000528	CcSEcCtD
Fulvestrant—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00013	0.000526	CcSEcCtD
Fulvestrant—Nausea—Valsartan—type 2 diabetes mellitus	0.00013	0.000525	CcSEcCtD
Fulvestrant—Constipation—Ramipril—type 2 diabetes mellitus	0.00013	0.000524	CcSEcCtD
Fulvestrant—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000129	0.000519	CcSEcCtD
Fulvestrant—Nausea—Orlistat—type 2 diabetes mellitus	0.000129	0.000518	CcSEcCtD
Fulvestrant—Asthenia—Losartan—type 2 diabetes mellitus	0.000127	0.000512	CcSEcCtD
Fulvestrant—Vomiting—Metformin—type 2 diabetes mellitus	0.000127	0.000511	CcSEcCtD
Fulvestrant—Rash—Metformin—type 2 diabetes mellitus	0.000126	0.000507	CcSEcCtD
Fulvestrant—Dermatitis—Metformin—type 2 diabetes mellitus	0.000126	0.000507	CcSEcCtD
Fulvestrant—Pruritus—Losartan—type 2 diabetes mellitus	0.000125	0.000505	CcSEcCtD
Fulvestrant—Headache—Metformin—type 2 diabetes mellitus	0.000125	0.000504	CcSEcCtD
Fulvestrant—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000124	0.000502	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000124	0.000501	CcSEcCtD
Fulvestrant—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000121	0.000489	CcSEcCtD
Fulvestrant—Urticaria—Ramipril—type 2 diabetes mellitus	0.000121	0.000486	CcSEcCtD
Fulvestrant—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00012	0.000484	CcSEcCtD
Fulvestrant—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00012	0.000484	CcSEcCtD
Fulvestrant—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00012	0.000482	CcSEcCtD
Fulvestrant—Rash—Irbesartan—type 2 diabetes mellitus	0.000119	0.000478	CcSEcCtD
Fulvestrant—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000119	0.000478	CcSEcCtD
Fulvestrant—Nausea—Metformin—type 2 diabetes mellitus	0.000118	0.000478	CcSEcCtD
Fulvestrant—Headache—Irbesartan—type 2 diabetes mellitus	0.000118	0.000475	CcSEcCtD
Fulvestrant—Dizziness—Losartan—type 2 diabetes mellitus	0.000117	0.000472	CcSEcCtD
Fulvestrant—Vomiting—Losartan—type 2 diabetes mellitus	0.000113	0.000454	CcSEcCtD
Fulvestrant—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000112	0.000451	CcSEcCtD
Fulvestrant—Nausea—Irbesartan—type 2 diabetes mellitus	0.000112	0.000451	CcSEcCtD
Fulvestrant—Rash—Losartan—type 2 diabetes mellitus	0.000112	0.00045	CcSEcCtD
Fulvestrant—Dermatitis—Losartan—type 2 diabetes mellitus	0.000112	0.00045	CcSEcCtD
Fulvestrant—Headache—Losartan—type 2 diabetes mellitus	0.000111	0.000447	CcSEcCtD
Fulvestrant—Asthenia—Ramipril—type 2 diabetes mellitus	0.000109	0.000439	CcSEcCtD
Fulvestrant—Pruritus—Ramipril—type 2 diabetes mellitus	0.000107	0.000433	CcSEcCtD
Fulvestrant—Nausea—Losartan—type 2 diabetes mellitus	0.000105	0.000424	CcSEcCtD
Fulvestrant—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000104	0.000419	CcSEcCtD
Fulvestrant—Dizziness—Ramipril—type 2 diabetes mellitus	0.0001	0.000405	CcSEcCtD
Fulvestrant—Vomiting—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000389	CcSEcCtD
Fulvestrant—Rash—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000386	CcSEcCtD
Fulvestrant—Dermatitis—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000386	CcSEcCtD
Fulvestrant—Headache—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000384	CcSEcCtD
Fulvestrant—Nausea—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000364	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—INS—type 2 diabetes mellitus	3.18e-05	0.000199	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR3C1—type 2 diabetes mellitus	3.15e-05	0.000197	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARA—type 2 diabetes mellitus	3.14e-05	0.000197	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.13e-05	0.000196	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—CDKN2B—type 2 diabetes mellitus	3.12e-05	0.000196	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SIRT1—type 2 diabetes mellitus	3.09e-05	0.000194	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.05e-05	0.000192	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AGT—type 2 diabetes mellitus	3.04e-05	0.00019	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	3.01e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SERPINE1—type 2 diabetes mellitus	3e-05	0.000188	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—type 2 diabetes mellitus	2.99e-05	0.000188	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CALM1—type 2 diabetes mellitus	2.99e-05	0.000187	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOE—type 2 diabetes mellitus	2.98e-05	0.000187	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	2.95e-05	0.000185	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARA—type 2 diabetes mellitus	2.95e-05	0.000185	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOA1—type 2 diabetes mellitus	2.94e-05	0.000184	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.92e-05	0.000183	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—type 2 diabetes mellitus	2.92e-05	0.000183	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.89e-05	0.000181	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.88e-05	0.000181	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	2.87e-05	0.00018	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.85e-05	0.000179	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GNB3—type 2 diabetes mellitus	2.85e-05	0.000179	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.85e-05	0.000179	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.85e-05	0.000178	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—type 2 diabetes mellitus	2.84e-05	0.000178	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAT—type 2 diabetes mellitus	2.8e-05	0.000176	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.79e-05	0.000175	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NOS3—type 2 diabetes mellitus	2.79e-05	0.000175	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.77e-05	0.000174	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR3C1—type 2 diabetes mellitus	2.74e-05	0.000172	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPP2CA—type 2 diabetes mellitus	2.73e-05	0.000171	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.72e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.72e-05	0.00017	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOB—type 2 diabetes mellitus	2.72e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.69e-05	0.000169	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—type 2 diabetes mellitus	2.64e-05	0.000166	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—LPL—type 2 diabetes mellitus	2.59e-05	0.000163	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—type 2 diabetes mellitus	2.59e-05	0.000163	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARA—type 2 diabetes mellitus	2.57e-05	0.000161	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—type 2 diabetes mellitus	2.55e-05	0.00016	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.54e-05	0.00016	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—INS—type 2 diabetes mellitus	2.54e-05	0.000159	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ADCY5—type 2 diabetes mellitus	2.54e-05	0.000159	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GPX1—type 2 diabetes mellitus	2.53e-05	0.000159	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.49e-05	0.000156	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.49e-05	0.000156	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CD36—type 2 diabetes mellitus	2.47e-05	0.000155	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.46e-05	0.000154	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—type 2 diabetes mellitus	2.44e-05	0.000153	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.43e-05	0.000153	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.39e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.38e-05	0.000149	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MTHFR—type 2 diabetes mellitus	2.34e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—type 2 diabetes mellitus	2.33e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—type 2 diabetes mellitus	2.3e-05	0.000144	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARA—type 2 diabetes mellitus	2.29e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.27e-05	0.000143	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NOS3—type 2 diabetes mellitus	2.23e-05	0.00014	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3R1—type 2 diabetes mellitus	2.23e-05	0.00014	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.22e-05	0.000139	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AGT—type 2 diabetes mellitus	2.22e-05	0.000139	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.21e-05	0.000139	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.19e-05	0.000138	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CALM1—type 2 diabetes mellitus	2.18e-05	0.000137	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.18e-05	0.000137	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOE—type 2 diabetes mellitus	2.17e-05	0.000136	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.17e-05	0.000136	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.15e-05	0.000135	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.15e-05	0.000135	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOA1—type 2 diabetes mellitus	2.15e-05	0.000135	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	2.13e-05	0.000134	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—type 2 diabetes mellitus	2.12e-05	0.000133	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—type 2 diabetes mellitus	2.12e-05	0.000133	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CTGF—type 2 diabetes mellitus	2.11e-05	0.000133	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.11e-05	0.000133	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—type 2 diabetes mellitus	2.04e-05	0.000128	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.03e-05	0.000128	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2e-05	0.000126	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.97e-05	0.000123	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.91e-05	0.00012	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—type 2 diabetes mellitus	1.89e-05	0.000119	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—INS—type 2 diabetes mellitus	1.86e-05	0.000117	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.83e-05	0.000115	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.81e-05	0.000114	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.8e-05	0.000113	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.8e-05	0.000113	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.77e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.75e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.75e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.72e-05	0.000108	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AR—type 2 diabetes mellitus	1.71e-05	0.000107	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—type 2 diabetes mellitus	1.7e-05	0.000107	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.69e-05	0.000106	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-05	0.000102	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-05	0.000102	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.57e-05	9.87e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.56e-05	9.79e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.56e-05	9.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.55e-05	9.73e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.54e-05	9.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.51e-05	9.5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.51e-05	9.44e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-05	9.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.47e-05	9.25e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.47e-05	9.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.44e-05	9.04e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.4e-05	8.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.4e-05	8.78e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.4e-05	8.77e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.4e-05	8.77e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR3C1—type 2 diabetes mellitus	1.38e-05	8.66e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.37e-05	8.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.36e-05	8.54e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.36e-05	8.5e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.33e-05	8.36e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.33e-05	8.36e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.33e-05	8.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.33e-05	8.32e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—type 2 diabetes mellitus	1.32e-05	8.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.31e-05	8.22e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARA—type 2 diabetes mellitus	1.29e-05	8.12e-05	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—type 2 diabetes mellitus	1.28e-05	8.04e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.23e-05	7.74e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.23e-05	7.72e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.23e-05	7.72e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.21e-05	7.61e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.21e-05	7.61e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.19e-05	7.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.19e-05	7.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.19e-05	7.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.19e-05	7.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.19e-05	7.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.19e-05	7.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.19e-05	7.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.15e-05	7.22e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.09e-05	6.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.09e-05	6.82e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	1.07e-05	6.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.06e-05	6.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.06e-05	6.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.05e-05	6.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.03e-05	6.47e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.03e-05	6.47e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.03e-05	6.44e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-05	6.43e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.02e-05	6.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.01e-05	6.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.01e-05	6.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.01e-05	6.34e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	9.98e-06	6.26e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.94e-06	6.23e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.82e-06	6.16e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.69e-06	6.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.69e-06	6.08e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	9.64e-06	6.04e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—type 2 diabetes mellitus	9.63e-06	6.04e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.53e-06	5.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.33e-06	5.85e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.33e-06	5.85e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.33e-06	5.85e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.16e-06	5.75e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.01e-06	5.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.01e-06	5.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.01e-06	5.65e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.94e-06	5.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.78e-06	5.5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	8.58e-06	5.38e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.47e-06	5.31e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—type 2 diabetes mellitus	8.39e-06	5.26e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.18e-06	5.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.16e-06	5.12e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.15e-06	5.11e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.01e-06	5.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.99e-06	5.01e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.99e-06	5.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.93e-06	4.97e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.89e-06	4.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.66e-06	4.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.66e-06	4.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.66e-06	4.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.66e-06	4.8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.53e-06	4.72e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—type 2 diabetes mellitus	7.49e-06	4.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.34e-06	4.61e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.12e-06	4.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.83e-06	4.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	6.82e-06	4.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.71e-06	4.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.6e-06	4.14e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.59e-06	4.13e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.37e-06	4e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.27e-06	3.93e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.24e-06	3.92e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.24e-06	3.92e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.12e-06	3.84e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.09e-06	3.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.09e-06	3.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.09e-06	3.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.05e-06	3.79e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.98e-06	3.75e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.98e-06	3.75e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.94e-06	3.72e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.87e-06	3.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.63e-06	3.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.46e-06	3.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.46e-06	3.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.46e-06	3.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.36e-06	3.36e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.31e-06	3.33e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.2e-06	3.26e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.08e-06	3.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.99e-06	3.13e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.94e-06	3.1e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.94e-06	3.1e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.8e-06	3.01e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.75e-06	2.98e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.73e-06	2.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.73e-06	2.97e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.43e-06	2.77e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.31e-06	2.7e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	4.23e-06	2.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.08e-06	2.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.08e-06	2.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.06e-06	2.55e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.01e-06	2.51e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.96e-06	2.48e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.89e-06	2.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.88e-06	2.43e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.78e-06	2.37e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.71e-06	2.33e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.64e-06	2.28e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.62e-06	2.27e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.53e-06	2.21e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.48e-06	2.19e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.34e-06	2.1e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.28e-06	2.06e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.18e-06	1.99e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.12e-06	1.96e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.11e-06	1.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.08e-06	1.93e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.98e-06	1.87e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.75e-06	1.72e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.71e-06	1.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.66e-06	1.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.44e-06	1.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.33e-06	1.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.33e-06	1.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.13e-06	1.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-06	6.72e-06	CbGpPWpGaD
